Drugs giant faces wait
619694
ASTRAZENECAâS anti-clotting drug Exanta is unlikely to win US approval in the near future, the company said as it revealed a delay with another new drug, Galida for diabetes.
475419
A billion dollar court case is delayed in Nigeria against a US pharmaceutical giant over a drug trial in which 11 children died.
253298
The drug company pushes on after the Enhance trials.
498617
TORONTO - The hearing into insider trading allegations leveled against the chairman of ATI Technologies has been pushed back until March 29.
286537
A battle between insurers and drug companies could determine how many medicines will be available to beneficiaries.
57476
Google's estimated $3bn flotation has been delayed by at least a day as the firm awaits regulatory approval.
643643
Drug-maker posts tepid results as it bides time before new products hit the market.
393731
Business & money: Insurer Resolution is under pressure to seek talks on a Â£35bn bid from rival Pearl Group.
519863
The company faces a pivotal clinical trial.
379179
Two months into Wal-MartÂs drug program, it is unclear whether offering $4 generic drugs is drawing new customers into the companyÂs stores.
287219
Deadline extended while the software maker waits for a ruling in Justice Department's antitrust case.
131142
NEW YORK/LONDON  - Several of the world's top   drugmakers may weigh acquiring Bristol-Myers Squibb Co. BMY.N   after it fired its chief executive, although suitors seem   unlikely to bid before next summer, analysts said.
149032
The stock is feeling some pain these days. However, this drugmaker has enough going for it that the illness shouldn&#39;t last. Amid nervousness over the future of Pfizer&#39;s arthritis pain treatment Celebrex and
416882
Competition for painkiller patch may prove to be a major pain for the generics maker.
343462
The company has to confront concerns over genetically modified foods soon if it hopes to keep growing.
201667
WALL STREET analysts last night said a second experimental pain killer under development by Merck, the American drugs maker, could be delayed until 2007, after regulators asked for more information on the medicineâs safety.
602915
Britain faces a shortage of a powerful painkiller used to treat cancer patients, the Department of Health reports. It said a supply problem with the opiate-based drug diamorphine meant stocks would soon reach